Body dysmorphic disorder among dermatologic patients: Prevalence and clinical features

Validation of the Body Dysmorphic Disorder Questionnaire in a community sample of Swedish women

“…For a second opinion a psychiatrist, who was experienced in diagnosing BDD, could be consulted via telephone. As the physical defect must be nonexistent or slight to meet the diagnostic criteria, the women's perceived appearance flaws were assessed by the interviewer using a Likert-scale, similar to rating scales used in previous research (Dufresne et al, 2001;Conroy et al, 2008;Conrado et al, 2010). The scale ranged from 1 to 3; 1 = no flaw present, 2 = minimal/slight flaw present, 3 = flaw present and clearly noticeable within conversational distance.…”

“…Subsequently the BDDQ has been widely used for BDD screening, e.g. with 1000 dermatology and plastic surgery outpatients (Vulink et al, 2006), 100 psychiatric inpatients (Conroy et al, 2008), 160 patients with maxillofacial problems (Vulink et al, 2008) and 300 dermatological patients (Conrado et al, 2010).…”

Prevalence and Clinical Features of Body Dismorphic Disorder on Psychiatric Inpatients: A Cross-sectional Study in Edirne/TURKEY

“…BDD prevalence in outpatients and hospitalized patients are 6.7-1.8% and 16.0-13.1%, respectively 3 . This rate may be as high as 25% in plastic surgery and dermatology departments 1,3,12,13 . In psychiatric outpatients clinics BDD prevalence is 3.2-0.8% [14][15][16] .…”

Body Dysmorphic Disorder : Capturing a prevalent but under-recognized disorder

“…Two studies used the SCID to diagnose BDD and found prevalence rates of 6.7% and 8.8% indicating that BDD is common in dermatology settings Conrado et al, 2010). Studies using the screening instrument BDDQ-DV found a prevalence of 4.2% in a Turkish sample (Dogruk Kacar et al, 2014) and about 14% in two US samples (Phillips et al, 2000;Bowe et al, 2007).…”

“…However, BDD seems to go unrecognized by dermatologists, plastic surgeons, and other physicians whom these patients approach dirst in their attempts to correct their perceived dlaws (Phillips, 2007). For example, of 31 patients diagnosed with BDD using the SCID in Brazilian dermatology settings, none had previously received a BDD diagnosis (Conrado et al, 2010). Understandably, it can be difdicult to determine if the concerns are 'markedly excessive' in a patient with a visible 'minor physical anomaly', but if physicians are not even aware of the BDD diagnosis, they may not enquire about the magnitude and the consequences of the concerns and may, thus, fail to detect this highly distressing disorder.…”